p.60 抽出テキスト
Myocardial Ischemia and Non-Obstructive Coronary Arteries: Pathogenic and Prognostic Implications. J Am Heart Assoc 2021; 10: e020535. PMID: 34259010 43. Pasupathy S, Air T, Dreyer RP, et al. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation 2015; 131: 861-870. PMID: 25587100 44. Smilowitz NR, Mahajan AM, Roe MT, et al. Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines). Circ Cardiovasc Qual Outcomes 2017; 10: e003443. PMID: 29246884 45. Lindahl B, Baron T, Erlinge D, et al. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease. Circulation 2017; 135: 1481-1489. PMID: 28179398 46. Montone RA, Niccoli G, Fracassi F, et al. Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests. Eur Heart J 2018; 39: 91-98. PMID: 29228159 47. Safdar B, Spatz ES, Dreyer RP, et al. Presentation, Clinical Profile, and Prognosis of Young Patients With Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): Results From the VIRGO Study. J Am Heart Assoc 2018; e009174. PMID: 29954744 48. Choo EH, Chang K, Lee KY, et al. KAMIR ‐ NIH Investigators. Prognosis and Predictors of Mortality in Patients Suffering Myocardial Infarction With Non-Obstructive Coronary Arteries. J Am Heart Assoc 2019; 8: e011990. PMID: 31284804 49. Eggers KM, Hjort M, Baron T, et al. Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries. J Intern Med 2019; 285: 419-428. PMID: 30474313 50. Dreyer RP, Tavella R, Curtis JP, et al. Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population. Eur Heart J 2020; 41: 870-878. PMID: 31222249 51. Ishii M, Kaikita K, Sakamoto K, et al. JROAD Investigators. Characteristics and in-hospital mortality of patients with myocardial infarction in the absence of obstructive coronary artery disease in super-aging society. Int J Cardiol 2020; 301: 108-113. PMID: 31740139 52. Pasupathy S, Lindahl B, Litwin P, et al. Survival in Patients With Suspected Myocardial Infarction With Nonobstructive Coronary Arteries: A Comprehensive Systematic Review and Meta-Analysis From the MINOCA Global Collaboration. Circ Cardiovasc Qual Outcomes 2021; 14: e007880. PMID: 34784229 53. Sueda S, Sakaue T. Coronary artery spasm-induced acute myocardial infarction in patients with myocardial infarction with non-obstructive coronary arteries. Heart Vessels 2021; 36: 1804-1810. PMID: 34213596 54. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol 1999; 33: 1442-1452. PMID: 10334407 55. Ong P, Athanasiadis A, Borgulya G, et al. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol 2012; 59: 655-662. PMID: 22322081 56. Suda A, Seitz A, Odaka Y, et al. Assessment of coronary vasomotor responses to acetylcholine in German and Japanese patients with epicardial coronary spasm more similarities than differences? Heart Vessels 2021; 36: 337-344. PMID: 33044621 57. Cohen AJ, Brauer M, Burnett R, et al. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet 2017; 389: 1907-1918. PMID: 28408086 58. Matsukawa R, Michikawa T, Ueda K, et al. Desert dust is a risk factor for the incidence of acute myocardial infarction in Western Japan. Circ Cardiovasc Qual Outcomes 2014; 7: 743-748. PMID: 25074374 59. Kojima S, Michikawa T, Ueda K, et al. Asian dust exposure triggers acute myocardial infarction. Eur Heart J 2017; 38: 3202-3208. PMID: 29020374 60. Ishii M, Seki T, Kaikita K, et al. JROAD Investigators. Short-term exposure to desert dust and the risk of acute myocardial infarction in Japan: a time-stratified case-crossover study. Eur J Epidemiol 2020; 35: 455-464. PMID: 31950372 61. Ishii M, Seki T, Kaikita K, et al. JROAD Investigators. Association of short-term exposure to air pollution with myocardial infarction with and without obstructive coronary artery disease. Eur J Prev Cardiol 2021; 28: 1435-1444. PMID: 34695220 62 Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993; 87: 76-79. PMID: 8419026 63. Takaoka K, Yoshimura M, Ogawa H, et al. Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: role of cigarette smoking. Int J Cardiol 2000; 72: 121-126. PMID: 10646952 64. Yoshimura M, Yasue H, Nakayama M, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 1998; 103: 65-69. PMID: 9737779 65. Hibi K, Ishigami T, Tamura K, et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998; 32: 521-526. PMID: 9740620 66. Shimasaki Y, Yasue H, Yoshimura M, et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998; 31: 1506-1510. PMID: 9626827 67. Mizuno Y, Harada E, Morita S, et al. East asian variant of aldehyde dehydrogenase 2 is associated with coronary spastic angina: Possible roles of reactive aldehydes and implications of alcohol flushing syndrome. Circulation 2015; 131: 1665-1673. PMID: 25759460 68. Mizuno Y, Hokimoto S, Harada E, et al. Variant Aldehyde Dehydrogenase 2 (ALDH2*2) Is a Risk Factor for Coronary Spasm and ST-Segment Elevation Myocardial Infarction. J Am Heart Assoc 2016; 5: e003247. PMID: 27153870 69. Pelliccia F, Pasceri V, Niccoli G, et al. Predictors of Mortality in Myocardial Infarction and Nonobstructed Coronary Arteries: A Systematic Review and Meta-Regression. Am J Med 2020; 133: 73-83. PMID: 31260664 70. Sörensson P, Ekenbäck C, Lundin M, et al. Early Comprehensive Cardiovascular Magnetic Resonance Imaging in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries. JACC Cardiovasc Imaging 2021; 14: 1774-1783. PMID: 33865778 71. Tateishi K, Saito Y, Kitahara H, et al. Safety and usefulness of acetylcholine provocation test in patients with no culprit lesions on emergency coronary angiography. Int J Cardiol 2018; 269: 27-30. PMID: 29980367 72. Probst S, Seitz A, Martínez Pereyra V, et al. Safety assessment and results of coronary spasm provocation testing in patients with myocardial infarction with unobstructed coronary arteries compared to patients with stable angina and unobstructed coronary arteries. Eur Heart J Acute Cardiovasc Care 2021; 10: 380-387. PMID: 32508106 73. Ishihara M, Sato H, Tateishi H, et al. Impaired coronary flow reserve immediately after coronary angioplasty in patients with acute myocardial infarction. Br Heart J 1993; 69: 288-292. PMID: 8489858 74. Merz CN, Kelsey SF, Pepine CJ, et al. The Women’s Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol 1999; 33: 1453-1461. PMID: 10334408 75. Bairey Merz CN, Shaw LJ, Reis SE, et al. WISE Investigators. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006; 47 Suppl: S21-S29. PMID: 16458167 76. Shaw LJ, Bairey Merz CN, Pepine CJ, et al. WISE Investigators. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 2006; 47 Suppl: S4-S20. PMID: 16458170 77. Shaw LJ, Shaw RE, Merz CN, et al. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation 2008; 117: 1787-1801. PMID: 18378615 78. Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med 2010; 362: 886-895. PMID: 20220183 79. Jespersen L, Hvelplund A, Abildstrøm SZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 2012; 33: 734-744. PMID: 21911339 80. Sara JD, Widmer RJ, Matsuzawa Y, et al. Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease. JACC Cardiovasc Interv 2015; 8: 1445-1453. PMID: 26404197 81. Ford TJ, Stanley B, Good R, et al. Stratified medical therapy using invasive coronary function testing in angina: The CorMicA trial. J Am Coll Cardiol 2018; 72: 2841-2855. PMID: 30266608